Clinical Trial: Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid Tumor
Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Observational
Official Title: Gene Expression (GE) and MicroRNA (MIRNA) Expression Profiles of Malignant Rhabdoid Tumors (MRT) of the Kidney (RTK) and Atypical Teratoid Rhabdoid T
Brief Summary:
RATIONALE: Studying biomarkers of tissue samples from patients with cancer in the laboratory may help doctors learn more about changes the occur in DNA and identify biomarkers related to cancer.
PURPOSE: This research trial studies biomarkers in samples from patients with rhabdoid tumor of the kidney and atypical teratoid rhabdoid tumor.
Detailed Summary:
OBJECTIVES:
Primary
- To determine if there are molecular differences between rhabdoid tumor of the kidney (RTK) and the atypical teratoid rhabdoid tumor (ATRT).
OUTLINE: Archived tumor tissue samples are analyzed for gene expression profile and microRNA profile.
Sponsor: Children's Oncology Group
Current Primary Outcome: Molecular differences between RTK and the ATRT
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Children's Oncology Group
Dates:
Date Received: October 1, 2011
Date Started: September 2011
Date Completion:
Last Updated: February 19, 2016
Last Verified: February 2016